We were told the inst cap raise was over subscribed for extras etc etc
But this cap raise looks like this to me:
Total issue: 698m, or excluding Hopu cornerstone with their entitlements, 447.5m
Hopu so far: 217.5m (31%)
Insts so far (assuming Hopu did not take extras in the inst): 119.5 (17%, or 27% excl H)
leaves:
Hopu extra they can take - assuming they haven't already???: 33m (5%)
Retail: 328m (47%, or 73% excl H)
Retail have to take well over 2.5 times what the insts did. In 7 years trading crap raisings for a living, I can't remember any like this, with such a whacky ratio. I'd love to know how this came about.
The percentage that are institutional would appear to be 57% minimum. From the annual report - the top 20 excluding 4 that may be retail, there seemed to be at least 558m out of 964m - which is 57% of the total just in the top 20. There will definitely be more insts outside the top 20. I guess I would assume 75% as a wild guess. So looks to me like at least half of these institutional holders decided not to take up their full entitlement, if any at all!
If you disagree - feel welcome to tell me where I am going wrong. This capital raising looks like it may be under heavy pressure, and that there is way too much supply without a home. Obviously too much supply will make the SP lower.
My opinion only - do your own research and don't rely on me.
- Forums
- ASX - By Stock
- PDN
- Questionable
Questionable
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDN (ASX) to my watchlist
|
|||||
Last
$13.80 |
Change
-0.190(1.36%) |
Mkt cap ! $4.125B |
Open | High | Low | Value | Volume |
$14.10 | $14.10 | $13.67 | $13.15M | 953.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 17228 | $13.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 2425 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7977 | 13.750 |
4 | 23754 | 13.740 |
1 | 3937 | 13.730 |
6 | 21584 | 13.720 |
1 | 2765 | 13.710 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 2585 | 2 |
13.840 | 1000 | 1 |
13.860 | 2000 | 1 |
13.880 | 4716 | 4 |
13.890 | 24424 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PDN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online